Table 2.
Comparison of procedural data between patients on rivaroxaban and warfarin
| Group | Sinus rhythm upon RFCA | Additional linear ablation | Cardioversion during RFCA | Procedural time (min) | Fluoroscopy time (min) | Early AF recurrence 90 d post-RFCA |
| Group R (n=30) | 10 (33.3%) | 20 (66.7%) | 15 (50.0%) | 156.0±52.3 | 26.0±11.1 | 5 (16.7%) |
| Group W (n=30) | 11 (36.7%) | 18 (60.0%) | 14 (46.7%) | 134.3±40.4 | 21.0±9.3 | 6 (20.0%) |
|
| ||||||
| P value | 0.79 | 0.59 | 0.80 | 0.11 | 0.08 | 0.74 |
Data are expressed as mean±SD or number (percentage). RFCA: radiofrequency catheter ablation; AF: atrial fibrillation